Skip to content

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Establishment Labs logo
Establishment LabsESTA
-164%-17.8pp

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s return on equity?
AirSculpt Technologies, Inc. (AIRS) reported return on equity of -21.6% in Q3 2025.
How has AirSculpt Technologies, Inc.'s return on equity changed year-over-year?
AirSculpt Technologies, Inc.'s return on equity decreased by 138.0% year-over-year, from -9.1% to -21.6%.
What is the long-term trend for AirSculpt Technologies, Inc.'s return on equity?
Over 2 years (2022 to 2024), AirSculpt Technologies, Inc.'s return on equity has grown at a -27.6% compound annual growth rate (CAGR), from -19% to -10%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.